Abstract
Background About 600 million people are estimated to be infected with Strongyloides stercoralis, the species that causes the vast majority of human strongyloidiasis cases. S. stercoralis can also infect non-human primates (NHPs), dogs and cats, rendering these animals putative sources for zoonotic human S. stercoralis infection. S. fuelleborni is normally found in old world NHPs but occasionally also infects humans, mainly in Africa. Dogs in southeast Asia carry at least two types of Strongyloides, only one of which appears to be shared with humans (“dog only” and “human and dog” types). For S. stercoralis with molecular taxonomic information, there is a strong sampling bias towards southeast and east Asia and Australia.
Methodology/Principle findings We collected human and dog derived Strongyloides spp. and hookworms from two locations in Bangladesh and subjected them to molecular taxonomic and genomic analysis based on nuclear and mitochondrial sequences. All hookworms found were Necator americanus. Contrary to earlier studies in Asia, we noticed a rather high incidence of S. fuelleborni in human samples. Also in this study, we found the two types of S. stercoralis and no indication for genetic isolation from the southeast Asian populations. However, we found one S. stercoralis worm in a human sample that genomically was of the “dog only” type and we found two worms in a dog sample that had the nuclear genomes of the “dog only” type but the mitochondrial genome of the “human and dog” type.
Conclusions/Significance S. fuelleborni may play a more prominent role as a human parasite in certain places in Asia than previously thought. The introgression of a mitochondria haplotype into the “dog only” population suggests that rare interbreeding between the two S. stercoralis types does occur and that exchange of genetic properties, for example a drug resistance, between the two types is conceivable.
Author Summary More than 600 million people are infected with the nematode intestinal parasite Strongyloides stercoralis. Dogs can also carry S. stercoralis. In southeast Asia different genetic types that either infect only dogs or humans and dogs were described. Strongyloides fuelleborni, (normally found in old-world monkeys) can also infect humans, mainly in Africa. We collected Strongyloides spp. and hook worms, from humans and a dog in Bangladesh and analyzed their nuclear and mitochondrial genomes. All hookworms were Necator americanus, one of the two major human hookworm species. Contrary to the general believe that human infections with S. fuelleborni are extremely rare in Asia, we found multiple such cases, suggesting that S. fuelleborni plays a more important role as a human parasite than previously thought also in Asia.
We found the two expected genetic types of S. stercoralis. For the first time we found a genomically “dog only” type worm in a person and we found two worms with nuclear genomes of the “dog only” type but mitochondrial genomes of the “human and dog” type. This suggest that rare interbreeding between the two types occurs, such that exchange of genetic properties, such as a drug resistance, between the two types is conceivable.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Max Planck Society (Max Planck Institute for Biology Tuebingen, core budget).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethical Review Committee, Sylhet Agricultural University Research System (SAURES), Bangladesh (SAURES-UGC-2022-04)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data are available in the manuscript, the supplementary materials or public databases under the accession numbers provided in the manuscript.